# Phytoncide Bioavailability and Pharmacokinetics

## α-Pinene Oral Administration (Schmidt & Göen, 2017)

### Source
Schmidt L, Göen T. Human metabolism of α-pinene and metabolite kinetics after oral administration. Arch Toxicol. 2017;91(3):1175-1185.

### Key Pharmacokinetic Parameters

**Oral Bioavailability**
- Total urinary recovery of metabolites: ~18% of oral dose
  - Myrtenic acid (MYRA): 6.7%
  - cis-Verbenol: 5.6%
  - trans-Verbenol: 4.1%
  - Myrtenol: 1.5%
- Indicates extensive first-pass metabolism and/or alternative elimination routes

**Absorption and Metabolism Speed**
- **Maximum blood/urine concentration**: 1.6 hours after oral ingestion
- **Elimination half-life**: 1.4-1.6 hours (very rapid)
- **Complete elimination**: Within 24 hours
- Metabolism dominated by oxidation reactions at methyl side-chains

**Clinical Significance**
- Fast metabolism suggests need for frequent dosing or continuous exposure
- Low oral bioavailability compared to inhalation route
- Rapid elimination means effects are transient without sustained exposure

---

## Inhalation vs Oral Bioavailability Comparison

### Inhalation Route (General Terpenes)
- **Bioavailability: 10-37%** for volatile compounds
- Direct absorption through lungs into bloodstream
- Bypasses first-pass hepatic metabolism
- Rapid onset of action (minutes)
- Higher peak concentrations achievable

### Oral Route (General Terpenes)
- **Bioavailability: 6-20%** depending on compound
- Subject to extensive first-pass metabolism in liver
- Slower onset (1-2 hours to peak)
- More sustained but lower concentrations
- Gut microbiota metabolism may produce beneficial metabolites

### Implications for NK Cell Activation
- **Inhalation provides 2-6x higher bioavailability** than oral route
- Forest bathing (inhalation) likely more effective than dietary intake alone
- Combination approach may provide both immediate and sustained effects

---

## Blood Concentrations of α-Pinene

### Background Environmental Exposure (NHANES Data)
- General population blood levels: 0.014 to 3.65 ng/mL
- Indicates ubiquitous low-level exposure from indoor/outdoor air

### Therapeutic Concentrations
- In vitro studies used 100 μM (~13,600 ng/mL) for NK cell activation
- Significant gap between environmental exposure and therapeutic concentrations
- Suggests need for intentional high-exposure practices (forest bathing, essential oils)

---

## Dietary Sources of Terpenes/Phytoncides

### High-Terpene Foods
1. **Citrus fruits** (limonene, α-pinene)
   - Oranges, lemons, grapefruits, mandarins
   - Highest concentration in peels/zest

2. **Herbs and spices** (various terpenes)
   - Rosemary, thyme, sage, basil, oregano
   - Garlic, onions (organosulfur compounds + terpenes)

3. **Mangoes** (myrcene)

4. **Apples** (various terpenes)

5. **Tea** (especially green tea - catechins + terpenes)

6. **Pine nuts** (α-pinene, β-pinene)

7. **Cruciferous vegetables** (glucosinolates + terpenes)
   - Broccoli, kale, Brussels sprouts

8. **Mushrooms** (terpenes + β-glucans for immune support)

### Bioavailability Enhancement Strategies
- Consume with healthy fats (terpenes are lipophilic)
- Fresh > dried (volatile compounds degrade)
- Raw or lightly cooked when possible
- Combine with black pepper (piperine enhances absorption)

---

## Critical Blind Spot Identified

**The Bioavailability Gap**: The user's framework does not account for the massive difference in bioavailability between routes of administration:

- **Inhalation (forest bathing, essential oils)**: 10-37% bioavailability
- **Oral (dietary)**: 6-20% bioavailability, rapid elimination

This means the framework's equal weighting may undervalue inhalation-based practices and overvalue dietary approaches for acute NK cell activation.

**Recommendation**: Bioavailability scoring should be route-specific, not just practice-specific.